Molecular Imaging: Page 108

Immuno-PET shows tumor response to therapy

By AuntMinnie.com staff writers

Immuno-PET imaging illuminates a tumor's response to therapy, which could translate into better treatment for patients with cancer, according to a study published in the March issue of the Journal of Nuclear Medicine.

March 14, 2021

AI reduces FDG dose on PET imaging

By Kate Madden Yee

An artificial intelligence (AI) algorithm can process F-18 FDG PET exams acquired at two-thirds of the standard radiopharmaceutical dose and produce diagnostically effective images, according to a study published March 9 in EJNMMI Physics.

March 11, 2021

BWXT, GMS form joint venture for Asia-Pacific

By AuntMinnie.com staff writers

BWX Technologies (BWXT) subsidiary and medical isotope and radiopharmaceutical supplier BWXT Medical has formed a joint venture for the Asia-Pacific region with nuclear medicine and radiopharmacy firm Global Medical Solutions (GMS).

March 8, 2021

Siemens gets FDA clearance for new PET/CT scanner

By AuntMinnie.com staff writers

Siemens Healthineers has received clearance from the U.S. Food and Drug Administration for Biograph Vision Quadra, a new PET/CT scanner with a large 106-cm axial field of view.

March 8, 2021

NorthStar, IBA expand Tc-99m collaboration

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes and proton therapy developer Ion Beam Applications (IBA) are expanding their collaboration in an effort to increase the supply of technetium-99m (Tc-99m) around the world.

March 7, 2021

Navidea signs deal for $5M in preferred shares

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has signed an agreement with the company's largest shareholder for a private placement of up to $5 million in preferred stock.

March 4, 2021

FDG-PET/MRI offers option for pediatric Hodgkin lymphoma

By Wayne Forrest

FDG-PET/MRI is a promising alternative to FDG-PET/CT for staging and gauging treatment response for Hodgkin lymphoma, with the benefit of less radiation to pediatric and adolescent patients, according to a study published online February 19 in the Journal of Nuclear Medicine.

March 4, 2021

NorthStar reorganizes to advance nuclear medicine agents

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has appointed its executive Dave Wilson to a new position as part of a reorganization it says will boost availability of molybdenum-99 in the U.S. and advance development of other radioisotopes.

March 3, 2021

FDA grants EBTATE investigational new drug status

By AuntMinnie.com staff writers

Biotechnology developer Molecular Targeting Technologies has received investigational new drug approval from U.S. Food and Drug Administration (FDA) to study EBTATE use in patients with neuroendocrine tumors.

March 2, 2021

ARTMS gets funds to develop Zr-89 for PET

By AuntMinnie.com staff writers

Canadian radioisotope developer ARTMS has received $300,000 Canadian from Innovate BC to help develop the radioisotope zirconium-89 (Zr-89) for PET for patients who are eligible for immuno-oncology therapies.

March 2, 2021

AuntMinnie.com Molecular Imaging Insider

By Brian Casey

March 2, 2021

CMS ends noncoverage of PET infection and inflammation

By AuntMinnie.com staff writers

The U.S. Centers for Medicare and Medicaid Services (CMS) has ended its longstanding national noncoverage policy for PET imaging for infection and inflammation, according to the Society of Nuclear Medicine and Molecular Imaging.

March 2, 2021

Previous Page

Page 108 of 620

Next Page